A Guide to Assessing Your Enhanced IncomeShield Plan [November 2025 Edition]

Recent revisions to Enhanced IncomeShield plans in October 2025 may prompt concerns about your existing coverage. This comprehensive guide addresses your key questions as we share thoughts on whether the coverage is still worth the premiums.

iFAST Insurance Team
iFAST Insurance Team 06 Nov 2025 9145 Views
A Guide to Assessing Your Enhanced IncomeShield Plan [November 2025 Edition]

With the changes to MediShield Life in April 2025, and the recent changes to Income’s Integrated Shield plans in October 2025, we feel that it is time for us to also share an update to our previous article: A Guide to assessing your Enhanced IncomeShield plan [October 2024 edition].

In this article, we review the differences between Enhanced IncomeShield Preferred and Advantage plans, assess if it is still recommended to keep your Preferred plan, and answer common questions that you may have on your Integrated Shield plans from Income.

If you have an old IncomeShield plan instead of an Enhanced IncomeShield plan, we share a detailed analysis on this in our next article.

MediShield Life vs Integrated Shield plans (IP)

  • MediShield Life (MSHL): A mandatory basic health insurance scheme, MSHL is administered by the CPF Board and provides universal coverage against large medical bills and specified outpatient treatments for all Singapore citizens and Permanent Residents (PRs).
  • Integrated Shield plans (IP): IP plans are optional hospitalisation insurance and is offered by seven private insurers. Consider adding on an IP plan if you would like to receive treatment at higher ward types or private hospitals. IP plans will also provide annual policy limits higher than that of MSHL. To check if you have an existing IP plan, you may log into CPF website > Healthcare dashboard.

Enhanced IncomeShield Preferred

Enhanced IncomeShield Advantage

Enhanced IncomeShield Basic

MediShield Life (MSHL)

Ward Entitlement

Private hospital

Class A ward in public hospitals

Class B1 ward in public hospitals

Class B2/C wards in public hospitals

Policy Annual Limit

$1,500,000

$1,000,000

$250,000

$150,000

What the different hospital ward classes mean:

  • Class A ward – Single bed, air-conditioned room with attached bathroom and television.
  • Class B1 ward – 4 to 5 bedder air-conditioned room with shared attached bathroom and television.
  • Class B2 ward – 6 bedder room with shared bathroom (bathroom may not be attached to room). Ward may be air-conditioned or fan ventilated.

Overview of Key Benefit Changes with effect from 1 October 2025

[For details on the changes, refer to this Your IncomeShield plan is changing in October 2025. This is what you should know.]

Building on our 2024 comparison of Enhanced IncomeShield Preferred and Advantage, we summarise the key differences below, factoring in the October 2025 benefit changes.

  • Annual policy limit and ward entitlement – The main difference between the two plans lies in their annual policy limit and ward entitlement benefit. Enhanced IncomeShield Preferred offers an annual policy limit of $1,500,000 and covers private hospital stays, while Enhanced IncomeShield Advantage has a lower annual policy limit of $1,000,000 (revised from the previous $500,000) with entitlement to Class A wards in public hospitals.
  • Pre- and post-hospitalisation benefits – While both plans offer 100 days of pre and post hospitalisation coverage for non-panel treatments, the difference lies in panel treatment coverage. Under the Preferred plan, coverage extends to 180 days before and after hospitalisation when treatment is received from panel providers. However, the Advantage plan provides 100 days of coverage regardless of whether the treatment is panel or non-panel.
  • Living organ donor benefit – Under the Preferred plan, the living donor organ transplant benefit provides as-charged coverage of up to $60,000 if the insured is a living organ donor. If the insured is the organ recipient, the plan also covers the necessary inpatient hospital expenses of the non-insured living organ donor, up to the same $60,000 limit. However, the Advantage plan offers up to $40,000 as charged coverage only if the insured is the living organ donor and this benefit does not extend to the non-insured’s living organ donor’s inpatient hospital treatment.
  • Inpatient psychiatric treatment benefit – Preferred plan’s benefit is as charged up to $20,000 as compared to Advantage plan’s benefit of as charged, up to $10,000.
  • Prosthesis benefit – Preferred plan provides an as charged benefit of up to $10,000 as compared to Advantage plan’s as charged benefit of up to $6,000.

With one of the key changes to the October 2025 revision being the premiums of plan and riders, we answer some common questions you may have for your Enhanced IncomeShield plans.

Q: Enhanced IncomeShield Advantage has revised its policy annual limit from $500,000 to $1 million. Should I opt for this plan instead?

With this recent increase in annual policy limit, the Enhanced IncomeShield Advantage plan does indeed look attractive. Here are two points to take into consideration when determining if an Advantage plan is suitable for you.

Firstly, the difference in ward entitlement between the two plans. The Preferred Plan provides access to private hospitals, whereas the Advantage Plan covers treatment in a Class A ward in public hospitals.

With the recent revision, we feel that an Advantage plan offers good value if you are comfortable with seeking treatment at public hospitals as Class A wards are essentially a single-bed private room. However, it is important to note that treatment at public hospitals may involve longer waiting times for consultations and procedures. Therefore, we recommend this option only if you can accept the potentially longer waiting times associated with public hospital care.

Secondly, we do not recommend the Advantage plan if you intend to seek treatment outside of your entitled ward type or at private hospitals. This is because the pro-ration factor under the Enhanced Advantage plan has been reduced in the October 2025 revision and will result in significantly higher out-of-pocket expenses if you get treated at private hospitals while covered under this plan.

If you are comfortable with the potential waiting times for public hospital care and do not foresee yourself getting treated at private hospitals, then the Enhanced IncomeShield Advantage plan may be an option to consider.

Q: Premiums for the Classic Care rider have seen the sharpest increases among individuals aged 31 to 40 with this averaging around 30% across various plans. Does the Classic Care rider still offer good value?

While the Deluxe Care Rider cost twice as much as the Classic Care Rider, the only difference between the two is the co-payment requirement on hospital bills. The Classic Care Rider requires a 10% co-payment, whereas the Deluxe Care Rider reduces this to just 5%. For both riders, the annual co-payment is capped at $3,000 per policy year for treatments from panel and extended panel providers.

With the main distinction between the two riders being the co-payment payable, the Classic Care rider offers good value for individuals who are comfortable with the higher 10% co-payment required.

  • For treatment at panel or extended panel providers,

As the co-payment required for both riders are capped at $3,000 per policy year for panel and extended-panel providers, individuals seeking treatment at panel providers will find this out-of-pocket payment more significant for smaller sized hospital bills. For example, a hospital bill of $30,000 incurred at a panel provider will require a co-payment of $1,500 under the Deluxe Care rider, while the Classic Care rider requires a co-payment of $3,000 giving it a difference of $1,500.

For larger hospital bills, this co-payment amount will reach the $3,000 cap quickly at panel providers. For example, while 10% of a $50,000 bill would be $5,000, the co-payment payable is limited to $3,000 with the cap. For bills exceeding $60,000 at a panel provider, both riders will result in the same maximum co-payment amount with co-payment capped at $3,000.

  • For treatment at non-panel providers,

Do note that the $3,000 co-payment cap applies only to treatments received from panel and extended panel providers. There is no co-payment limit for treatments from non-panel providers. If you foresee yourself visiting a non-panel provider for treatment, you may incur higher out-of-pocket expenses, as no cap will apply to the co-payment portion.

Q: The premium increase in October 2025 is exceptionally high when a Deluxe Care rider is added to an Enhanced Advantage plan. Should I still opt for this Enhanced IncomeShield Advantage with Deluxe Care rider combination?

The October 2025 revision has resulted in an exceptionally high increase in rider premiums for the Enhanced Advantage plan. This is applicable to both Deluxe Care and Classic Care rider (for ages between 1 to 40) whose premiums have increased by as much as 33% when added to an Advantage plan.

In our article last year, we concluded that you could be better off adding a Deluxe Care rider to your Advantage plan instead of having just a Preferred plan alone. Our 2025 review maintains this stance. Despite the recent premium adjustments, we still believe that it makes financial sense to downgrade your IP plan and add a rider. Riders offer great value with less out-of-pocket expenses because of the capped co-payment for panel and extended panel treatments and provide higher cancer drug benefit limits.

Furthermore, even after the revisions, the Advantage plan with Deluxe Care rider combination continues to offer lower premiums as compared to a Preferred plan alone. Notably, the Enhanced IncomeShield Advantage plan with Deluxe Care rider combination is now cheaper for most age groups as compared to the previous pricing.

Do note that the above analysis is based on the features of the current plans offered. With integrated shield plans and riders being a yearly renewable plan, these features are not guaranteed, and plans may be subjected to changes by the insurer in future.

Q: With this premium increase, what should I do if I currently have an Enhanced IncomeShield Preferred plan?

If you are unsure whether to maintain your Enhanced IncomeShield Preferred plan or to adjust your coverage, ask yourself these two questions:

(1) Are you able to afford the current premiums required,

(2) Are you willing to seek treatment at public hospitals albeit the potentially longer waiting time required for consultation and treatments.

If you can afford your current premiums, we recommend keeping your existing coverage as plans are yearly renewable and may be subjected to changes in future. Furthermore, you may always adjust your plan in future if the need arises and it would be easier to downgrade than to upgrade your plan in future.

Note: While premiums are an important factor to consider, they should not be your only consideration. As Integrated Shield Plans are yearly renewable and subjected to potential premium adjustments by insurers, there is no guarantee that a plan offering the lowest premium today will continue to do so in future.

However, if you are currently holding on to an Enhanced IncomeShield Preferred plan with a Deluxe Care rider and are unable to afford the premiums, here are two options to consider:

  • If you value ward entitlement more,

Keep: Enhanced IncomeShield Preferred (IP plan)

Downgrade: Deluxe Care rider to Classic Care rider (IP rider)

Consider keeping your IP plan and downgrading your rider instead. Switching from a Deluxe Care rider to a Classic Care rider could reduce your premiums by up to 42% while allowing you to continue enjoying coverage at private hospitals.

The trade-off in doing so is that you are now required to pay a higher co-payment (10%). If you intend to visit panel or extended panel providers, this may not be off a huge concern as co-payment is capped at $3,000 per policy year. However, if you visit non-panel providers, note that there is no cap to the amount of co-payment payable and you should be prepared to pay a higher co-payment amount for your medical bills.

  • If you value a lower co-payment amount,

Keep: Deluxe Care rider (IP rider)

Downgrade: Enhanced IncomeShield Preferred to Enhanced IncomeShield Advantage (IP plan)

If you value having a lower co-payment amount, keep your Deluxe Care rider and instead downgrade your IP plan from a private hospital plan (Enhanced IncomeShield Preferred) to a Class A ward plan (Enhanced IncomeShield Advantage). Doing so will allow you to maintain the 5% co-payment payable on your hospital bills while allowing you to pay up to 79% less in premiums.

Alternatively, if premiums are still a concern, you may also consider opting for the Advantage plan with a Classic Care rider. As explained in our previous point, the main difference between the Classic Care and Deluxe Care rider is the co-payment percentage required by the plan. If you intend to seek treatment at panel or extended panel providers, this difference in co-payment required may not be significant

[✨Don’t Miss!] Receive a $88 FSMOne Cash Account Reward* when you trust FSMOne for your insurance needs

A close-up of a red background

AI-generated content may be incorrect.

From now till 31 December 2025, take charge of your insurance needs and reach out to us for a complimentary review. Receive expert guidance on your coverage and get a $88 FSMOne Cash Account Reward* when you successfully review your insurance with us. You may also get up to 45% commission rebates on eligible policies! Get covered confidently and get rewarded. Click here to get started.

Have a question on your insurance? Reach out to us for a complimentary review.

Yes, I'm Interested!

*Terms and conditions apply. Read more here.

Read also,

Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)

from AIA, AIG, Allianz, China Taiping, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.

*Please check with our team if the product you want is available on FSMOne Insurance

Information obtained from:
https://www.income.com.sg/health-insurance/enhanced-incomeshield
https://www.income.com.sg/kcassets/5a9edd0d-c5fd-44b6-8767-1eb64c99cd91/Enhanced%20IncomeShield%20policy%20conditions%201%20Oct%202025.pdf
https://www.income.com.sg/kcassets/00cc233f-4cfe-4282-a036-0d91fa99e44e/Premium%20Table%20EIS.pdf
https://www.income.com.sg/kcassets/524f8f56-0bcb-4f17-ae58-eb8dd79cdcaf/Premium%20Table%20Deluxe%20Care%20Rider%20EIS.pdf
https://www.income.com.sg/kcassets/489230e4-264c-40bf-99f2-1fe71632bcd0/Premium%20Table%20Classic%20Care%20Rider%20EIS.pdf
Information retrieved on 28 October 2025.

Disclaimer:
All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This article is not a contract of insurance.
Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.
You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.
While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.
The comparisons and opinions provided are based on publicly available data/information and are intended to provide a general overview of the insurance products discussed. These comparisons do not cover all available products and may not fully illustrate every aspect of the products discussed.
Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.
This advertisement has not been reviewed by the Monetary Authority of Singapore.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.